These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36692682)

  • 1. Optimization of the radiation dosimetry protocol in Lutetium-177-PSMA therapy: toward clinical implementation.
    Peters SMB; Mink MCT; Privé BM; de Bakker M; de Lange F; Muselaers CHJ; Mehra N; Witjes JA; Gotthardt M; Nagarajah J; Konijnenberg MW
    EJNMMI Res; 2023 Jan; 13(1):6. PubMed ID: 36692682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-therapeutic dosimetry of [
    Peters SMB; Privé BM; de Bakker M; de Lange F; Jentzen W; Eek A; Muselaers CHJ; Mehra N; Witjes JA; Gotthardt M; Nagarajah J; Konijnenberg MW
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):460-469. PubMed ID: 34218300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ and tumor dosimetry including method simplification for [
    Karimzadeh A; Schatz L; Sauer M; Apostolova I; Buchert R; Klutmann S; Lehnert W
    EJNMMI Phys; 2024 Jul; 11(1):63. PubMed ID: 39017988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining Absorbed Doses of Indigenously Developed
    Kamaldeep ; Wanage G; Sahu SK; Maletha P; Adnan A; Suman S; Basu S; Das T; Banerjee S
    Cancer Biother Radiopharm; 2021 Apr; 36(3):292-304. PubMed ID: 32379495
    [No Abstract]   [Full Text] [Related]  

  • 5. [
    Peters SMB; Hofferber R; Privé BM; de Bakker M; Gotthardt M; Janssen M; de Lange F; Muselaers CHJ; Mehra N; Witjes JA; Costa PF; Nagarajah J; Konijnenberg MW; Jentzen W
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1101-1112. PubMed ID: 34623453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [
    Resch S; Ziegler SI; Sheikh G; Unterrainer LM; Zacherl MJ; Bartenstein P; Böning G; Brosch-Lenz J; Delker A
    J Nucl Med; 2024 Aug; 65(8):1272-1278. PubMed ID: 38936975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT.
    Grob D; Privé BM; Muselaers CHJ; Mehra N; Nagarajah J; Konijnenberg MW; Peters SMB
    EJNMMI Phys; 2024 Apr; 11(1):34. PubMed ID: 38568428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward Single-Time-Point Image-Based Dosimetry of
    Brosch-Lenz J; Delker A; Völter F; Unterrainer LM; Kaiser L; Bartenstein P; Ziegler S; Rahmim A; Uribe C; Böning G
    J Nucl Med; 2023 May; 64(5):767-774. PubMed ID: 36657980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry of
    Violet J; Jackson P; Ferdinandus J; Sandhu S; Akhurst T; Iravani A; Kong G; Kumar AR; Thang SP; Eu P; Scalzo M; Murphy D; Williams S; Hicks RJ; Hofman MS
    J Nucl Med; 2019 Apr; 60(4):517-523. PubMed ID: 30291192
    [No Abstract]   [Full Text] [Related]  

  • 10. Kidney absorbed radiation doses for [ 177 Lu]Lu-PSMA-617 and [ 177 Lu]Lu-PSMA-I&T determined by 3D clinical dosimetry.
    Uijen MJM; Privé BM; van Herpen CML; Westdorp H; van Gemert WA; de Bakker M; Gotthardt M; Konijnenberg MW; Peters SMB; Nagarajah J
    Nucl Med Commun; 2023 Apr; 44(4):270-275. PubMed ID: 36597884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer.
    Delker A; Fendler WP; Kratochwil C; Brunegraf A; Gosewisch A; Gildehaus FJ; Tritschler S; Stief CG; Kopka K; Haberkorn U; Bartenstein P; Böning G
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):42-51. PubMed ID: 26318602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA
    Gosewisch A; Delker A; Tattenberg S; Ilhan H; Todica A; Brosch J; Vomacka L; Brunegraf A; Gildehaus FJ; Ziegler S; Bartenstein P; Böning G
    EJNMMI Res; 2018 Aug; 8(1):76. PubMed ID: 30076556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative post-therapeutic dosimetry between 2D planar-based and hybrid-based methods for personalized Lu-177 treatment.
    Handayani W; Chantadisai M; Phromphao B; Noipinit N; Pasawang P; Khamwan K
    Ann Nucl Med; 2024 Nov; 38(11):884-893. PubMed ID: 39023826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-in-human dosimetry of gastrin-releasing peptide receptor antagonist [
    Kurth J; Krause BJ; Schwarzenböck SM; Bergner C; Hakenberg OW; Heuschkel M
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):123-135. PubMed ID: 31482426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lutetium-177-PSMA-617 in Low-Volume Hormone-Sensitive Metastatic Prostate Cancer: A Prospective Pilot Study.
    Privé BM; Peters SMB; Muselaers CHJ; van Oort IM; Janssen MJR; Sedelaar JPM; Konijnenberg MW; Zámecnik P; Uijen MJM; Schilham MGM; Eek A; Scheenen TWJ; Verzijlbergen JF; Gerritsen WR; Mehra N; Kerkmeijer LGW; Smeenk RJ; Somford DM; van Basten JA; Heskamp S; Barentsz JO; Gotthardt M; Witjes JA; Nagarajah J
    Clin Cancer Res; 2021 Jul; 27(13):3595-3601. PubMed ID: 33883176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer.
    Yadav MP; Ballal S; Tripathi M; Damle NA; Sahoo RK; Seth A; Bal C
    Nucl Med Commun; 2017 Jan; 38(1):91-98. PubMed ID: 27782913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretherapeutic 68Ga-PSMA-617 PET May Indicate the Dosimetry of 177Lu-PSMA-617 and 177Lu-EB-PSMA-617 in Main Organs and Tumor Lesions.
    Wang J; Zang J; Wang H; Liu Q; Li F; Lin Y; Huo L; Jacobson O; Niu G; Fan X; Zhu Z; Chen X
    Clin Nucl Med; 2019 Jun; 44(6):431-438. PubMed ID: 30985422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT.
    Gosewisch A; Ilhan H; Tattenberg S; Mairani A; Parodi K; Brosch J; Kaiser L; Gildehaus FJ; Todica A; Ziegler S; Bartenstein P; Böning G
    EJNMMI Res; 2019 Aug; 9(1):76. PubMed ID: 31414241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streamlined Schemes for Dosimetry of
    Kurth J; Heuschkel M; Tonn A; Schildt A; Hakenberg OW; Krause BJ; Schwarzenböck SM
    Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is a single late SPECT/CT based kidney
    Beykan S; Tran-Gia J; Borup Jensen S; Lassmann M
    Phys Med; 2022 Aug; 100():39-50. PubMed ID: 35724608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.